Comparison of pre- versus post-meal administration of voglibose in men with or without impaired glucose tolerance

Diabetes Research and Clinical Practice

Volumn 83, Issue 2, 2009, Pages

  Aoki, Kazutaka ^a   Ito, Yuzuru ^a   Saito, Kaori ^a   Shirakawa, Jun ^a   Togashi, Yu ^a   Satoh, Kouichiro ^a   Muraoka, Tomonori ^a   Shinoda, Kazuaki ^a   Masuda, Kiyomi ^a   Kimura, Mari ^a   Terauchi, Yasuo ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

GI; Post prandial glucose; Type 2 diabetes; Voglibose

Indexed keywords

GLITAZONE DERIVATIVE; INSULIN; MIGLITOL; PIOGLITAZONE; VOGLIBOSE;

AREA UNDER THE CURVE; DIABETES MELLITUS; DRUG EFFECT; DRUG EFFICACY; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESPONSE; INTERMETHOD COMPARISON; LETTER; WEIGHT GAIN;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; EATING; GLUCOSE INTOLERANCE; HUMANS; HYPOGLYCEMIC AGENTS; INOSITOL; INSULIN; MALE; POSTPRANDIAL PERIOD;

EID: 58249099269     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.11.009     Document Type: Letter

References (5)

1. Aoki K., Nakamura A., Ito S., Nezu U., Iwasaki T., Takahashi M., et al. Administration of miglitol until 30 min after the start of a meal is effective in type 2 diabetic patients. Diabetes Res. Clin. Pract. 78 (2007) 30-33
2. Aoki K., Kato H., and Terauchi Y. Divided-dose administration of miglitol just before and 15 minutes after the start of a meal smoothes postprandial plasma glucose excursions and serum insulin responses in healthy men. Endocr. J. 54 (2007) 1009-1014
3. Aoki K., Nakajima S., Nezu U., Shinoda K., and Terauchi Y. Comparison of pre- versus post-meal administration of miglitol for 3 months in type 2 diabetic patients. Diabetes Obes. Metab. 10 (2008) 970-972
4. Rosak C., Nitzsche G., Konig P., and Hofmann U. The effect of the timing and the administration of acarbose on postprandial hyperglycaemia. Diabet. Med. 12 (1995) 979-984
5. Negishi M., Shimomura K., Proks P., Shimomura Y., and Mori M. Alpha glucosidase inhibitor voglibose can prevent pioglitazone-induced body weight gain in type 2 diabetic patients. Br. J. Clin. Pharmacol. 66 (2008) 318-319